Multinational generic drug authorization pilot a hit with companies
This article was originally published in SRA
Executive Summary
Generic drug makers have shown a high level of interest in taking part in an international scheme that was launched last July to test the feasibility of synchronizing their marketing authorizations across different jurisdictions1,2.